Remyelination varies between and within lesions in multiple sclerosis following bexarotene. (2022)

First Author: Brown JWL
Attributed to:  Dementias Platform UK Stem Cell Partnership funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/acn3.51662

PubMed Identifier: 36116011

Publication URI: http://europepmc.org/abstract/MED/36116011

Type: Journal Article/Review

Volume: 9

Parent Publication: Annals of clinical and translational neurology

Issue: 10

ISSN: 2328-9503